StockWatch
·
Pharmaceuticals
Corporate Governance5 Nov 2026, 05:22 pm

Rubicon Research: IPO Proceeds Utilization Report for Q2 FY27

AI Summary

Rubicon Research Limited has submitted its Monitoring Agency Report for the quarter ended September 30, 2026, detailing the utilization of funds raised through its Initial Public Offering (IPO). The report, issued by India Ratings and Research Private Limited, confirms no deviation from the stated objects of the IPO. This conclusion is based on management representations and a certificate from statutory auditors Deloitte Haskins & Sells LLP. The IPO, which occurred between October 9-13, 2025, raised INR 5,000 Million through a fresh issue, with a total issue size of INR 13,775.00 Million. The company's Audit Committee and Board of Directors have reviewed and taken this report on record.

Key Highlights

  • No deviation from IPO objects observed for Q2 FY27.
  • Report issued by India Ratings and Research Private Limited.
  • IPO raised INR 5,000 Million via fresh issue.
  • Audit Committee and Board have taken the report on record.